Adapting to the new consensus guidelines for managing hyperglycemia during critical illness: The updated yale insulin infusion protocol

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 363-370

  Shetty, Shilpa ^a   Inzucchi, Silvio E ^b,c   Goldberg, Philip A ^b   Cooper, Dawn ^c   Siegel, Mark D ^b,c   Honiden, Shyoko ^b,c  

^a GRIFFIN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; HYPERTENSIVE FACTOR; INSULIN;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ENTERIC FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARENTERAL NUTRITION;

EID: 84861076097     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11260.OR     Document Type: Article

References (22)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
2. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospec-tive randomised multi-centre controlled trial on tight glu-cose control by intensive insulin therapy in adult intensive care units: The Glucontrol study. Intensive Care Med. 2009; 35:1738-1748.
3. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insu-lin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
4. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
5. Inzucchi SE, Siegel MD. Glucose control in the ICU-how tight is too tight? N Engl J Med. 2009;360:1346-1349.
6. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion pro-tocol in a medical intensive care unit. Diabetes Care. 2004; 27:461-467.
7. Faraon-Pogaceanu C, Banasiak KJ, Hirshberg EL, Faustino EV. Comparison of the effectiveness and safety of two insulin infusion protocols in the management of hyperglycemia in critically ill children. Pediatr Crit Care Med. 2010;11:741-749.
8. Tamaki M, Shimizu T, Kanazawa A, et al. Efficacy and safety of modified Yale insulin infusion protocol in Japanese diabetic patients after open-heart surgery. Diabetes Res Clin Pract. 2008;81:296-302.
9. Goldberg PA, Roussel MG, Inzucchi SE. Clinical results of an updated insulin infusion protocol in critically ill patients. Diabetes Spectr. 2005;18:188-191.
10. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: An algorithm for glycemic con-trol (Erratum in: Endocr Pract. 2009;15:768-770).
11. Endocr Pract. 2009;15:540-559.
12. Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
13. Malmberg K. Prospective randomised study of inten-sive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997;314:1512-1515.
14. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the inci-dence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999; 67:352-360; discussion 360-362.
15. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
16. Vriesendorp TM, van Santen S, DeVries JH, et al. Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med. 2006;34:96-101.
17. Goldberg PA, Sakharova OV, Barrett PW, et al. Improving glycemic control in the cardiothoracic intensive care unit: Clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18:690-697.
18. Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL. Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery. 2008;144:629-635; discussion 635-637.
19. Cao SG, Ren JA, Shen B, Chen D, Zhou YB, Li JS. Intensive versus conventional insulin therapy in type 2 dia-betes patients undergoing D2 gastrectomy for gastric can-cer: A randomized controlled trial. World J Surg. 2011;35: 85-92.
20. Eachempati SR, Hydo LJ, Shou J, Barie PS. Implementation of tight glucose control for critically ill surgical patients: A process improvement analysis. Surg Infect (Larchmt). 2009;10:523-531.
21. Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: A randomized con-trolled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190-3197.
22. De La Rosa Gdel C, Donado JH, Restrepo AH, et al; Grupo de Investigacion en Cuidado intensivo: GICI-HPTU. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: A ran-domised clinical trial. Crit Care. 2008;12:R120.